Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial

References

• Gayen S. Malignant pleural effusion: presentation, diagnosis, and management. Am J Med. 2022;135(10):1188–1192. doi: 10.1016/j.amjmed.2022.04.017.
   PubMed Web of Science ®Google Scholar
• Hodge C, Badgwell BD. Palliation of malignant ascites. J Surg Oncol. 2019;120(1):67–73. doi: 10.1002/jso.25453.
   PubMed Web of Science ®Google Scholar
• Barni S, Cabiddu M, Ghilardi M, et al. A novel perspective for an orphan problem: old and new drugs for the medical management of malignant ascites. Crit Rev Oncol Hematol. 2011;79(2):144–153. doi: 10.1016/j.critrevonc.2010.07.016.
   PubMed Web of Science ®Google Scholar
• Spiliotis J, Halkia E, de Bree E. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Curr Oncol. 2016;23(3):e266-75–e275. doi: 10.3747/co.23.2831.
   PubMed Web of Science ®Google Scholar
• Kulandaisamy PC, et al. Malignant pleural Effusions-A review of current guidelines and practices. J Clin Med. 2021;10(23):5535.
   PubMed Web of Science ®Google Scholar
• Di Leo A, Corvasce A, Weindelmayer J, et al. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pseudomyxoma peritonei of appendiceal origin: result of a single Centre study. Updates Surg. 2020;72(4):1207–1212. doi: 10.1007/s13304-020-00788-5.
   PubMed Web of Science ®Google Scholar
• Morris MC, Dhar VK, Stevenson MA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) for patients at High-Risk of peritoneal metastases. Surg Oncol. 2019;31:33–37. doi: 10.1016/j.suronc.2019.09.002.
   PubMed Web of Science ®Google Scholar
• Faviana P, Boldrini L, Musco B, et al. Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center. In Vivo. 2020;34(4):2061–2066. doi: 10.21873/invivo.12008.
   PubMed Web of Science ®Google Scholar
• Jiao J, Li C, Yu G, et al. Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites. World J Surg Oncol. 2020;18(1):180. doi: 10.1186/s12957-020-01956-y.
   PubMed Web of Science ®Google Scholar
• Nikiforchin A, Gushchin V, King MC, et al. Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for patients with intrapleural dissemination of peritoneal surface malignancies. Ann Surg Oncol. 2021;28(13):9126–9135. doi: 10.1245/s10434-021-10298-2.
   PubMed Web of Science ®Google Scholar
• Aprile V, et al. Hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: the forefront of Surgery-Based multimodality treatment. J Clin Med. 2021;10(17):3801.
   PubMed Web of Science ®Google Scholar
• Dawson AG, Kutywayo K, Mohammed SB, et al. Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review. Thorax. 2023;78(4):409–417. doi: 10.1136/thoraxjnl-2021-218214.
   PubMed Web of Science ®Google Scholar
• Ried M, Eichhorn M, Winter H, et al. [Expert recommendation for the implementation of hyperthermic intrathoracic chemotherapy (HITOC) in Germany]. Zentralbl Chir. 2020;145(1):89–98. doi: 10.1055/a-0934-7806.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou Y-F, Liang H, et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol. 2016;22(30):6906–6916. doi: 10.3748/wjg.v22.i30.6906.
   PubMed Web of Science ®Google Scholar
• Turaga K, Levine E, Barone R, et al. Consensus guidelines from the American society of peritoneal surface malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol. 2014;21(5):1501–1505. doi: 10.1245/s10434-013-3061-z.
   PubMed Web of Science ®Google Scholar
• Liu L, Sun L, Zhang N, et al. A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer. Int J Hyperthermia. 2022;39(1):239–245. doi: 10.1080/02656736.2022.2028018.
   PubMed Web of Science ®Google Scholar
• Cui S, Ba M, Tang Y, et al. B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites. Oncol Rep. 2012;28(4):1325–1331. doi: 10.3892/or.2012.1913.
   PubMed Web of Science ®Google Scholar
• Lu C, Li L, Luo Z, et al. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites. Neoplasma. 2016;63(2):299–303. doi: 10.4149/217_150622N345.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang N, Min J, et al. Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC). Oncotarget. 2016;7(16):21570–21578. doi: 10.18632/oncotarget.7622.
   PubMedGoogle Scholar
• Urano M. Kinetics of thermotolerance in normal and tumor tissues: a review. Cancer Res. 1986;46(2):474–482.
   PubMed Web of Science ®Google Scholar
• Ba M-C, Cui S-Z, Lin S-Q, et al. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World J Gastroenterol. 2010;16(15):1901–1907. doi: 10.3748/wjg.v16.i15.1901.
   PubMed Web of Science ®Google Scholar
• Badrudin D, Sideris L, Perrault-Mercier C, et al. Comparison of open and closed abdomen techniques for the delivery of intraperitoneal pemetrexed using a murine model. J Surg Oncol. 2018;117(6):1318–1322. doi: 10.1002/jso.24960.
   PubMed Web of Science ®Google Scholar
• Weisberger AS, Levine B, Storaasli JP. Use of nitrogen mustard in treatment of serous offusions of neoplastic origin. J Am Med Assoc. 1955;159(18):1704–1707. doi: 10.1001/jama.1955.02960350004002.
   PubMed Web of Science ®Google Scholar
• Spratt JS, Adcock RA, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40(2):256–260.
   PubMed Web of Science ®Google Scholar
• Yellin A, Simansky DA, Paley M, et al. Hyperthermic pleural perfusion with cisplatin: early clinical experience. Cancer. 2001;92(8):2197–2203. doi: 10.1002/1097-0142(20011015)92:8<2197::AID-CNCR1563>3.0.CO;2-F.
   PubMed Web of Science ®Google Scholar
• Matsuzaki Y, Shibata K, Yoshioka M, et al. Intrapleural perfusion hyperthermo-chemotherapy for malignant pleural dissemination and effusion. Ann Thorac Surg. 1995;59(1):127–131. doi: 10.1016/0003-4975(94)00614-D.
   PubMed Web of Science ®Google Scholar
• Ishibashi H, Kobayashi M, Takasaki C, et al. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy. Gen Thorac Cardiovasc Surg. 2015;63(7):395–400. doi: 10.1007/s11748-015-0535-x.
   PubMedGoogle Scholar
• Hofmann HS, Ried M. [Hyperthermic intrathoracic chemotherapy in thoracic surgery]. Chirurg. 2019;90(8):681–694. doi: 10.1007/s00104-019-0989-y.
   PubMed Web of Science ®Google Scholar
• Yasukawa M, Matsuo K, Matsuzaki S, et al. Management of recurrent granulosa cell tumor of the ovary: contemporary literature review and a proposal of hyperthermic intraperitoneal chemotherapy as novel therapeutic option. J Obstet Gynaecol Res. 2021;47(1):44–51. doi: 10.1111/jog.14494.
   PubMed Web of Science ®Google Scholar
• Baratti D, Kusamura S, Niger M, et al. Colorectal peritoneal metastases treated by perioperative systemic chemotherapy and cytoreductive surgery with or without mitomycin C-Based HIPEC: a comparative study using the peritoneal surface disease severity score (PSDSS). Ann Surg Oncol. 2021;28(6):3332–3342. doi: 10.1245/s10434-019-07935-2.
   PubMedGoogle Scholar
• Yi E, Kim D, Cho S, et al. Clinical outcomes of cytoreductive surgery combined with intrapleural perfusion of hyperthermic chemotherapy in advanced lung adenocarcinoma with pleural dissemination. J Thorac Dis. 2016;8(7):1550–1560. doi: 10.21037/jtd.2016.06.04.
   PubMed Web of Science ®Google Scholar
• Aprile V, Bacchin D, Korasidis S, et al. Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile? Interact Cardiovasc Thorac Surg. 2020;30(5):765–772. doi: 10.1093/icvts/ivaa019.
   PubMed Web of Science ®Google Scholar